LMATLeMaitre Vascular, Inc.Healthcare · Medical - Instruments & Suppliesas of 2026-09-16
Horizon

Issued 2026-09-16 at $80.38 · now $80.38 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, LMAT has typically landed between $68.86 and $93.22 — a range of −14.3% to +16.0% from the issuance price $80.38.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,986 overlapping 1 month windows · 2006-10-19 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($80.38) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where LMAT has typically landed a month from the 2026-09-16 close of $80.38 — the range is history, not a prediction.

$68.86worst · -14.3%$93.22best · +16.0%
  • now $80.38 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $81.49 (+1.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $77–$85.98
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $68.86–$93.22
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,986 windows spanning 2006-10-19 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2008-02-11−41.4%−41.4%+0.0%
2008-02-07−41.0%−41.0%+0.0%
2008-02-14−39.4%−41.4%+0.0%
3 best
2009-03-16+61.1%+0.0%+61.1%
2009-03-18+53.8%+0.0%+55.5%
2009-03-13+46.1%−6.2%+46.1%

4,986 overlapping windows · 2006-10-19 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
60%
−0.1%
n=20
Feb
55%
+3.0%
n=20
Mar
55%
−0.8%
n=20
Apr
65%
+3.2%
n=20
May
60%
+1.0%
n=20
Jun
70%
+4.4%
n=20
Jul
75%
+6.1%
n=20
Aug
60%
+1.8%
n=20
Sep
55%
+0.4%
n=20
Oct
32%
−3.6%
n=19
Nov
70%
+3.9%
n=20
Dec
60%
+0.0%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$117$792026-05-08: 2 insider sales, $3.3M — LeMaitre George W, Kamke Trent G2026-05-07: 3 insider sales, $3.0M — LeMaitre George W, Ross Bridget A, Jasinski Lawrence J2026-03-11: 2 insider sales, $641K — Roberts David B, Kamke Trent G2026-03-02: 1 insider sale, $6.0M — LeMaitre George W2026-02-27: 2 insider sales, $1.0M — Roberts David B, Kamke Trent G2026-02-26: 1 insider sale, $16.0M — LeMaitre George W2025-08: 9 open-market sales, $11.4M2026-02: 3 open-market sales, $17.0M2026-03: 3 open-market sales, $6.7M2026-05: 5 open-market sales, $6.3M↑ buys↓ salesdirector LeMaitre George W — Sale on 2026-05-08, filed 3 days after the tradeofficer Kamke Trent G — Sale on 2026-05-08, filed 3 days after the tradedirector LeMaitre George W — Sale on 2026-05-07, filed 4 days after the tradedirector Ross Bridget A — Sale on 2026-05-07, filed 4 days after the tradedirector Jasinski Lawrence J — Sale on 2026-05-07, filed 4 days after the tradedirector Roberts David B — Sale on 2026-03-11, filed 2 days after the tradeofficer Kamke Trent G — Sale on 2026-03-11, filed 2 days after the tradedirector LeMaitre George W — Sale on 2026-03-02, filed same daydirector Roberts David B — Sale on 2026-02-27, filed 3 days after the tradeofficer Kamke Trent G — Sale on 2026-02-27, filed 3 days after the tradedirector LeMaitre George W — Sale on 2026-02-26, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-05-08LeMaitre George WdirectorSale27,881 @ $108.69$3.0M−1.9% of holding−10.2%not yet — horizon still open1,430,019Form 4 · filed 3 days after the trade
2026-05-08Kamke Trent GofficerSale2,928 @ $107.00$313K−43.9% of holding−10.2%not yet — horizon still open3,749Form 4 · filed 3 days after the trade
2026-05-07LeMaitre George WdirectorSale18,600 @ $107.64$2.0M−1.3% of holding−12.7%not yet — horizon still open1,457,900Form 4 · filed 4 days after the trade
2026-05-07Ross Bridget AdirectorSale5,044 @ $111.10$560K−56.1% of holding−12.7%not yet — horizon still open3,942Form 4 · filed 4 days after the trade
2026-05-07Jasinski Lawrence JdirectorSale3,943 @ $110.00$434K−45.5% of holding−12.7%not yet — horizon still open4,714Form 4 · filed 4 days after the trade
2026-03-11Roberts David BdirectorSale3,312 @ $107.68$357K−18.4% of holding+5.3%−39.6%14,667Form 4 · filed 2 days after the trade
2026-03-11Kamke Trent GofficerSale2,625 @ $108.50$285K−28.2% of holding+5.3%−39.6%6,677Form 4 · filed 2 days after the trade
2026-03-02LeMaitre George WdirectorSale55,930 @ $107.81$6.0M−3.6% of holding+6.9%−37.2%1,476,500Form 4 · filed same day
2026-02-27Roberts David BdirectorSale8,464 @ $106.80$904K−32.0% of holding+6.6%−38.0%17,979Form 4 · filed 3 days after the trade
2026-02-27Kamke Trent GofficerSale1,044 @ $110.29$115K−13.5% of holding+6.6%−38.0%6,677Form 4 · filed 3 days after the trade
2026-02-26LeMaitre George WdirectorSale150,000 @ $106.76$16.0M−8.9% of holding+1.8%−42.0%1,532,304Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

289 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-03O'Connor John JamesdirectorAward / grant16Form 4
2026-09-03Roberts David BdirectorAward / grant318Form 4
2026-09-03Pellegrino Joseph P JRdirectorAward / grant225Form 4
2026-09-03LeMaitre George WdirectorAward / grant1070Form 4
2026-09-03Pellegrino Joseph P JRdirectorAward / grant432Form 4
2026-09-03O'Connor John JamesdirectorAward / grant16Form 4
2026-09-03Roush John AdirectorAward / grant16Form 4
2026-09-03LeMaitre George WdirectorAward / grant554Form 4
2026-09-03LeMaitre George WdirectorAward / grant1367Form 4
2026-09-03SHADAN MARTHAdirectorAward / grant24Form 4
2026-09-03SHADAN MARTHAdirectorAward / grant16Form 4
2026-09-03O'Connor John JamesdirectorAward / grant15Form 4
2026-09-03Roberts David BdirectorAward / grant514Form 4
2026-09-03Roberts David BdirectorAward / grant225Form 4
2026-09-03Kamke Trent GofficerAward / grant49Form 4
2026-09-03Pellegrino Joseph P JRdirectorAward / grant423Form 4
2026-09-03SHADAN MARTHAdirectorAward / grant15Form 4
2026-09-03LeMaitre George WdirectorAward / grant553Form 4
2026-09-03Roush John AdirectorAward / grant15Form 4
2026-09-03Roush John AdirectorAward / grant16Form 4
2026-09-03Roberts David BdirectorAward / grant432Form 4
2026-09-03Roberts David BdirectorAward / grant430Form 4
2026-09-03Pellegrino Joseph P JRdirectorAward / grant24Form 4
2026-09-03Kamke Trent GofficerAward / grant213Form 4
2026-09-03SHADAN MARTHAdirectorAward / grant16Form 4
2026-09-03O'Connor John JamesdirectorAward / grant15Form 4
2026-09-03Roberts David BdirectorAward / grant02Form 4
2026-09-03Kamke Trent GofficerAward / grant111Form 4
2026-09-03LeBlanc Dorian PaulofficerAward / grant317Form 4
2026-09-03Jasinski Lawrence JdirectorAward / grant16Form 4
2026-09-03LeMaitre George WdirectorAward / grant2051Form 4
2026-09-03Kamke Trent GofficerAward / grant215Form 4
2026-09-03Kamke Trent GofficerAward / grant214Form 4
2026-09-03Kamke Trent GofficerAward / grant212Form 4
2026-09-03LeMaitre George WdirectorAward / grant865Form 4
2026-09-03LeBlanc Dorian PaulofficerAward / grant49Form 4
2026-09-03SHADAN MARTHAdirectorAward / grant15Form 4
2026-09-03Roberts David BdirectorAward / grant225Form 4
2026-09-03Roberts David BdirectorAward / grant419Form 4
2026-09-03Jasinski Lawrence JdirectorAward / grant24Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.